RET and prostate carcinoma: However, the co-dependency with RET revealed the association of ZBTB7A in SCN HI cells, suggesting that co-dependency analysis with RET, a possible emerging NEPC target, can distinguish the roles of ZBTB7A in different prostate cancer subtypes.